Erik Hedner

Erik is specialised in areas related to drug development and regulatory CMC. After a PhD in Medicinal Chemistry, he worked as a CMC assessor at the Swedish Medicinal Products Agency. He has since held various expert positions within pharma consulting, primarily with a focus on phase I-III projects.